BeiGene Ltd. ADR (BGNE) Social Stream
BEIGENE LTD (BGNE) Price Targets From Analysts
Use the tables below to see what analysts covering BEIGENE LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $431 | $343.3 | $403.716 | $181.47 | 122.47% |
| 2022-01-06 | 6 | $431 | $283.3 | $392.46 | $181.47 | 116.27% |
| 2022-01-12 | 6 | $431 | $283.3 | $388.716 | $181.47 | 114.2% |
| 2022-01-18 | 6 | $431 | $283.3 | $380.883 | $181.47 | 109.89% |
| 2022-01-28 | 6 | $431 | $283.3 | $367.55 | $181.47 | 102.54% |
| 2022-02-08 | 6 | $431 | $283.3 | $354.216 | $181.47 | 95.19% |
| 2022-02-25 | 6 | $431 | $283.3 | $348.55 | $181.47 | 92.07% |
| 2022-02-28 | 6 | $431 | $254 | $332.333 | $181.47 | 83.13% |
| 2022-03-17 | 6 | $431 | $177 | $300.2 | $181.47 | 65.43% |
| 2022-04-28 | 6 | $431 | $177 | $313.166 | $181.47 | 72.57% |
| 2022-05-06 | 6 | $431 | $177 | $296.166 | $181.47 | 63.2% |
| 2022-05-18 | 6 | $431 | $177 | $289.833 | $181.47 | 59.71% |
| 2022-07-27 | 6 | $431 | $177 | $288.666 | $181.47 | 59.07% |
| 2022-08-05 | 6 | $431 | $177 | $284.316 | $181.47 | 56.67% |
| 2022-08-09 | 6 | $431 | $177 | $271.983 | $181.47 | 49.88% |
| 2022-09-17 | 6 | $431 | $177 | $270.6 | $181.47 | 49.12% |
| 2022-10-03 | 6 | $431 | $177 | $269.433 | $181.47 | 48.47% |
| 2022-10-13 | 6 | $296 | $200 | $236.433 | $181.47 | 30.29% |
| 2022-11-14 | 7 | $296 | $205 | $240.266 | $181.47 | 32.4% |
| 2022-12-12 | 7 | $296 | $205 | $244.6 | $181.47 | 34.79% |
| 2022-12-15 | 7 | $302 | $205 | $245.6 | $181.47 | 35.34% |
| 2023-01-19 | 6 | $302 | $205 | $256.266 | $181.47 | 41.22% |
| 2023-01-24 | 6 | $325 | $205 | $261.266 | $181.47 | 43.97% |
| 2023-02-07 | 7 | $325 | $205 | $261.266 | $181.47 | 43.97% |
| 2023-02-20 | 7 | $325 | $205 | $266.316 | $181.47 | 46.75% |
| 2023-02-28 | 7 | $350 | $230.1 | $294.183 | $181.47 | 62.11% |
| 2023-04-12 | 7 | $350 | $262 | $298.883 | $181.47 | 64.7% |
| 2023-04-25 | 6 | $350 | $262 | $298.883 | $181.47 | 64.7% |
| 2023-05-05 | 6 | $350 | $263.3 | $305.883 | $181.47 | 68.56% |
| 2023-05-09 | 6 | $350 | $263.3 | $306.55 | $181.47 | 68.93% |
| 2023-06-26 | 6 | $350 | $257 | $299.383 | $181.47 | 64.98% |
| 2023-06-30 | 7 | $350 | $196 | $284.614 | $181.47 | 56.84% |
| 2023-07-12 | 7 | $350 | $196 | $279.214 | $181.47 | 53.86% |
| 2023-07-17 | 8 | $350 | $196 | $278.687 | $181.47 | 53.57% |
| 2023-08-03 | 8 | $350 | $196 | $276.025 | $181.47 | 52.11% |
| 2023-08-04 | 8 | $350 | $196 | $277.275 | $181.47 | 52.79% |
| 2023-08-07 | 8 | $350 | $196 | $277.15 | $181.47 | 52.72% |
| 2023-08-17 | 8 | $350 | $196 | $275.525 | $181.47 | 51.83% |
| 2023-09-06 | 8 | $350 | $196 | $275.275 | $181.47 | 51.69% |
| 2023-09-12 | 9 | $350 | $196 | $275.677 | $181.47 | 51.91% |
| 2023-09-20 | 9 | $350 | $196 | $273.888 | $181.47 | 50.93% |
| 2023-09-28 | 9 | $350 | $196 | $275.555 | $181.47 | 51.85% |
| 2023-10-16 | 9 | $350 | $180.1 | $272.011 | $181.47 | 49.89% |
| 2023-10-26 | 9 | $350 | $180.1 | $262.9 | $181.47 | 44.87% |
| 2023-10-27 | 9 | $350 | $180.1 | $262.344 | $181.47 | 44.57% |
| 2023-11-10 | 9 | $350 | $196 | $264.333 | $181.47 | 45.66% |
| 2023-11-15 | 9 | $350 | $196 | $264.222 | $181.47 | 45.6% |
The Trend in the Analyst Price Target
Over the past 42 months, BGNE's average price target has gone up $73.99.
Over the past 43 weeks, BGNE's average upside potential has been 33.34%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 7 | 325 | 205.0 | 261.266 | 261.63 | -0.14% |
| 2023-04-12 | 6 | 350 | 230.1 | 293.350 | 254.88 | 15.09% |
| 2023-06-30 | 7 | 350 | 196.0 | 284.614 | 178.30 | 59.63% |
| 2023-08-03 | 8 | 350 | 196.0 | 276.025 | 205.82 | 34.11% |
| 2023-09-21 | 9 | 350 | 196.0 | 275.555 | 187.78 | 46.74% |
BGNE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.44 | 7 | 0 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
BGNE's average broker recommendation rating improved by 0.13 over the prior 45 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- BGNE has a higher average analyst price target than 5462.68% of all US stocks.
- BGNE has a higher number of analysts covering the stock than 612.34% of stocks in the large market cap category.
- BEIGENE LTD's upside potential (average analyst target price relative to current price) is greater than 4778.8% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BEIGENE LTD's variance in analysts' estimates is lower than -1906.73% of them.
In the Pharmaceutical Products industry, GRFS, CTLT, and PRGO are the three stocks most similar to BEIGENE LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding BGNE using the data that counts. Try POWR Ratings for free.